Loading…
Loading…
NGVT does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for NGVT and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for NGVT and 80,000+ other tickers.
See exactly how NGVT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NGVT and 80,000+ other tickers.
Ingevity Corporation (NGVT) is a global provider specializing in the production and distribution of advanced chemical solutions and activated carbon products. The company's reach extends across North America, the Asia Pacific region, Europe, the Middle East, Africa, and South America. Its business operations are organized into two principal divisions: Performance Materials and Performance Chemicals. The Performance Materials segment focuses on the engineering, manufacturing, and sale of chemically activated carbon products, primarily derived from hardwood. These materials are chiefly utilized…
NGVT's 19.2% YTD rally is backed by portfolio optimization, stronger hybrid demand, pricing gains and higher margins, fueling earnings growth.
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity will participate in a fireside chat during the 2026 Jefferies Industrials Conference.
Canada Pension Plan Investment Board purchased a new stake in Ingevity Corporation (NYSE: NGVT) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 14,900 shares of the company's stock, valued at approximately $1,113,000. Several other institutional investors have also recently made changes to
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Ingevity is transforming into a focused, high-margin regulatory compounder, emphasizing Performance Materials and Pavement Technologies after divesting volatile, lower-quality segments. Q2 '26 results highlight margin inflection: adjusted EBITDA rose 14% to $115M, margin expanded to 36.6%, and EPS increased to $1.74, demonstrating strong operating leverage. Hybrid vehicle adoption and infrastructure spending underpin resilient demand for NGVT's emissions-control and pavement solutions, while PFAS filtration offers incremental EBITDA growth optionality.